India  

‘Covaxin’s efficacy expected to be more than 90%’: PGI Rohtak’s V-C

Video Credit: HT Digital Content - Duration: 02:29s - Published
‘Covaxin’s efficacy expected to be more than 90%’: PGI Rohtak’s V-C

‘Covaxin’s efficacy expected to be more than 90%’: PGI Rohtak’s V-C

The third-phase trial of Bharat Biotech's Covid-19 vaccine candidate, Covaxin will begin from November 20.

Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, hopes to get 1,000 healthy volunteers for the third-phase, informed Vice-Chancellor OP Kalra.

"We are hoping to get 1,000 healthy volunteers by Thursday.

Of them, 200 volunteers will be administered the Covaxin initially so that we get to know about their antibody response.

There are three centers in the country where antibody response is studied.

If the response is good in 600 volunteers, then ICMR will take permission for market authentication so that mass production can be done," Kalra said.

He further said, "Two doses will be injected to each volunteer.

The second dose will be administered after 28 days of giving the first dose.” Watch the full video for more.


You Might Like


💡 newsR Knowledge: Other News Mentions

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

What to expect in the Chancellor's Budget 2021 [Video]

What to expect in the Chancellor's Budget 2021

A look at what to expect in Chancellor Rishi Sunak's Budget when he delivers it in Parliament on March 3.Mr Sunak has said he "is preparing a Budget that provides support for people" as Covid lockdown rules are eased.

Credit: PA - Press Association STUDIO    Duration: 02:23Published

February Covid cases at 9-month low; weekly tally up

There were 3,53,750 new cases of the coronavirus in February, a big drop from the number reported in the previous month, when infections had risen by more than..
IndiaTimes
Residents in several European express frustrations at COVID measures [Video]

Residents in several European express frustrations at COVID measures

"I am limited in my freedom. Not to mention the kids. They can't go to school. Learning online? What future will they have?" one demonstrator in Hungary said.

Credit: euronews (in English)    Duration: 01:50Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Brazil to buy 20 million Covid-19 vaccines from India's Bharat Biotech

Brazil's health ministry on Thursday signed a contract to purchase 20 million doses of Covaxin, the Covid-19 vaccine made by India's Bharat Biotech, for delivery..
IndiaTimes
TN Health Min takes Bharat Biotech's Covaxin shot in Chennai [Video]

TN Health Min takes Bharat Biotech's Covaxin shot in Chennai

The Health and Family Welfare Minister of Tamil Nadu, Dr C Vijayabaskar took Bharat Biotech's Covaxin shot. He took the shot in Chennai on morning of January 22. Dr C Vijayabaskar requested all to get vaccinated and safeguard themselves from COVID-19 pandemic. Billed as the world's largest vaccination programme, covering the entire length and breadth of the country, the drive aims to first inoculate millions of its healthcare and frontline workers and reach an estimated 3 crore people by the end of its first phase. The mega COVID-19 vaccination drive began in India on January 16 (Saturday).

Credit: ANI    Duration: 01:28Published
Healthcare workers should be given choice in vaccines: Karnataka resident doctors [Video]

Healthcare workers should be given choice in vaccines: Karnataka resident doctors

Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based Bharat Biotech's Covaxin, they want to take. "Government of India has approved Covishield and Covaxin vaccines. We have all the reports for Covishield. But, Covaxin is still in phase-III trials, where the trial is being done on healthcare workers. We condemn this...Healthcare workers should be given a choice of vaccine," said Dr Dayanand Sagar. GoI rolled out COVID-19 vaccine jab from January 16.

Credit: ANI    Duration: 01:30Published

Rohtak Rohtak Municipal Corporation in Haryana, India

Watch: Woman in hurry gets trapped beneath goods train while trying to cross railway track [Video]

Watch: Woman in hurry gets trapped beneath goods train while trying to cross railway track

An elderly woman had a miraculous escape, after being trapped beneath a goods train in Rohtak. Despite stopping by locals and signal man, she tried to cross the railway track when the goods train was stopped at a signal. While crossing the track, the train started moving and the woman got trapped beneath it. The locals told her to stay still till the train leaves.

Credit: ANI    Duration: 01:55Published
Joint team of Delhi, Haryana police arrests main accuse of Rohtak firing case [Video]

Joint team of Delhi, Haryana police arrests main accuse of Rohtak firing case

Joint team of Delhi and Haryana police arrested the main accuse of Rohtak firing case in Samaypur Badli on February 13. Three people were killed after a firing incident took place in a Rohtak college on the night of February 12. Five others were injured and rushed to hospital.

Credit: ANI    Duration: 01:21Published
3 killed in firing at Rohtak college [Video]

3 killed in firing at Rohtak college

Three people killed after a firing incident took place in a Rohtak college on the night of February 12. Five others were injured and rushed to hospital. More details awaited.

Credit: ANI    Duration: 01:16Published

Indian Council of Medical Research Indian Council of Medical Research

COVID: India reports 16,577 new cases [Video]

COVID: India reports 16,577 new cases

On February 26, total COVID-19 tally of India reached to 1,10,63,491. The country reported 16,577 new COVID-19 cases in last 24 hours and active cases stand at 1,55,986 . With new 12,179 discharges, total number reached to 1,07,50,680. 120 deaths were reported in last 24 hours, taking cumulative toll to 1,56,825. 1,34,72,643 beneficiaries have been vaccinated for COVID-19 across India. According to ICMR, total number of samples tested up to Feb 25 is 21,46,61,465 including 8,31,807 samples tested yesterday.

Credit: ANI    Duration: 01:19Published
COVID: Spike of 16,000 cases in India [Video]

COVID: Spike of 16,000 cases in India

On February 25, the total COVID-19 tally of India reached to 1,10,46,914. The country reported 16,738 new COVID-19 cases in last 24 hours and active cases stands at 1,51,708. With new 11,799 discharges, total number reached to 1,07,38,501. 138 deaths were reported in last 24 hours, taking cumulative toll to 1,56,705. 1,26,71,163 beneficiaries have been vaccinated for COVID-19 across India. According to Indian Council of Medical Research (ICMR), 21,38,29,658 samples tested up to 24th February.

Credit: ANI    Duration: 01:53Published

No evidence so far to link surge in Covid cases to new variants: ICMR

Even as some states witness a sudden spike in Covid cases, the scientific evidence so far does not suggest any link between new variants of coronavirus detected..
IndiaTimes

India's COVID-19 vaccines will be effective against new variants: ICMR

Stressing on the efficacy of indigenous COVID-19 vaccines, the Indian Council of Medical Research (ICMR) on Thursday said interim results of the ongoing clinical..
DNA

Related videos from verified sources

Covaxin's efficacy expected to be more than 90%: Dr OP Kalra [Video]

Covaxin's efficacy expected to be more than 90%: Dr OP Kalra

Vice-Chancellor of Pt BD Sharma University of Health Sciences, (Rohtak), OP Kalra during a press conference on November 18 said that the third phase of Covaxin will start from November 20. OP Kalra..

Credit: ANI     Duration: 01:58Published